Looking forward to a great meeting!

Epigenetic CRISPR screening in human T cells reveals that BATF3 overexpression enhances T cell function, reduces exhaustion, and boosts CAR T cell potency in both in vitro and in vivo tumor models. #NBThighlight nature.com/articles/s4158…

Using a new CRISPR-based methodology, a team of researchers led by Charles Gersbach Duke University has identified a “master regulator” gene capable of dramatically improving T-cell therapy performance >>> bit.ly/47vsnwN

Epigenetic control is incredibly powerful for bolstering cell therapy. We’re very excited to continue to build on the foundation established with this publication.